Imaging with 11Carbon labelled PET tracers

Nuclear Medicine Communications

Volumn 31, Issue 7, 2010, Pages 613-616

  Fanti, Stefano ^a   Nanni, Cristina ^a   Lopci, Egesta ^a   Castellucci, Paolo ^a   Rubello, Domenico ^b   Farsad, Mohsen ^c   Boschi, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c Abteilung fur Nuklearmedizin   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPAMINE F 18; ACETIC ACID C 11; CARBON 11; CATECHOLAMINE; CHOLINE C 11; CHOLINE F 18; FLUOROACETIC ACID; FLUORODEOXYGLUCOSE F 18; IODINE 123; IODINE 131; METHIONINE C 11; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADRENAL CORTEX; CATECHOLAMINE METABOLISM; DIAGNOSTIC ACCURACY; EDITORIAL; HALF LIFE TIME; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; PROTEIN METABOLISM;

ACETATES; ADRENAL CORTEX; CARBON RADIOISOTOPES; CATECHOLAMINES; CHOLINE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; RADIOACTIVE TRACERS; RECEPTORS, ADRENERGIC;

EID: 77953342436     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833c42ef     Document Type: Editorial

References (26)

1. Hübner KF, Andrews GA, Buonocore E, Hayes RL, Washburn LC, Collmann IR, et al. Carbon-11-labeled amino acids for the rectilinear and positron tomographic imaging of the human pancreas. J Nucl Med 1979; 20:507-513.
2. Bergström M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 1983; 7:1062-1066.
3. Friedland RP, Mathis CA, Budinger TF, Moyer BR, Rosen M. Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication. J Nucl Med 1983; 249:812-815.
4. Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987; 76:687-696.
5. Hara T, Kosada N, Kondo T, Kishi H, Kobori O. Imaging of brain tumor, lung cancer, esophageal cancer, colon cancer, prostate cancer and bladder cancer with (C-11)choline [abstract]. J Nucl Med 1997; 38:250P.
6. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon- 11-choline. J Nucl Med 1998; 39:990-995.
7. Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, et al. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 2009; 50:1394-1400.
8. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, et al. Detection and localization of prostate cancer: Correlation of 11C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005; 46:1642-1649.
9. Krause BJ, Souvatzoglou M, Tincel M, Herrmann K, Buck AK, Praus C, et al. The detection rate of 11-C choline PET/TC depends on the serum PSAvalue in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008; 35:18-23.
10. Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 2008; 35:253-263.
11. Hoffman RM. Altered methionine metabolism, DNA methylation and oncogenic expression in carcinogenesis. Biochem Biophys Acta 1984; 738:49-87.
12. Groves AM, Win Th, Ben Haim S, Ell PJ. Non-[18F]FDG PET in clinical oncology. Lancet Oncol 2007; 8:822-830.
13. Hatazawa J, Ishiwata K, Itoh M, Kameyama M, Kubota K, Ido T, et al. Quantitative evaluation of L-[methyl-C-11]methionine uptake in tumor using positron emission tomography. J Nucl Med 1989; 30:1809-1813.
14. Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, et al. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005; 32:52-59.
15. Herholz K, Hölzer T, Bauer B, Schröder R, Voges J, Ernestus RI, et al. 11-C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50:1316-1322.
16. Yamane T, Sakamoto S, Senda M. Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm. Eur J Nucl Med Mol Imaging 2009; 37:685-690.
17. Mittendorfer B, Sidossis LS, Walser E, Chinkes DL, Wolfe RR. Regional acetate kinetics and oxidation in human volunteers. Am J Physiol 1998; 274 (6 Pt 1):E978-E983. (Pubitemid 28308781)
18. Hwang KH, Choi DJ, Lee SY, Lee MK, Choe W. Evaluation of patients with hepatocellular carcinomas using [(11)C]acetate and [(18)F]FDG PET/CT: a preliminary study. Appl Radiat Isot 2009; 67:1195-1198.
19. Soloviev D, Fini A, Chierichetti F, Al-Nahhas A, Rubello D. PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. Eur J Nucl Med Mol Imaging 2008; 35:942-949.
20. Nanni C, Castellucci P, Farsad M, Rubello D, Fanti S. 11C/18F-choline PET or 11C/8F-acetate PET in prostate cancer: may a choice be recommended? Eur J Nucl Med Mol Imaging 2007; 34:1704-1705.
21. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature 1983; 305:137-138.
22. Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, et al. Imaging of advanced neuroendocrine tumors with (18)FFDOPA PET. J Nucl Med 2004; 45:1161-1167.
23. Hardy O, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H, et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr 2007; 150:140-145.
24. Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, et al. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol 2008; 26:1489-1495.
25. Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, et al. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 2006; 47:1635-1642.
26. Bergström M, Sörensen J, Kahn TS, Juhlin C, Eriksson B, Sundin A, et al. PETwith [11C]-Metomidate for the visualization of adrenocortical tumors and discrimination from other lesions. Clin Positron Imaging 1999; 2:339.